PAUL L. SHALLENBERGER, M.D., F.A.C.P.; DAVID F. KAPP, M.D.
Since its recognition as a clinical entity, acute pancreatitis continues to be a thorn in the flesh of diagnostic and therapeutic medicine. Although more than a quarter of a century has passed since Elman, Arneson and Graham1 found an elevation of the serum amylase to be of diagnostic significance, and although elaborate tests for pancreatic dysfunction have been developed, the initial diagnosis of acute pancreatitis today is missed in 65 to 75% of cases. Our lack of knowledge concerning this malady is further betrayed by the multitude of theories attempting to explain the pathogenesis and subsequent treatment. In order to
PAUL L. SHALLENBERGER, DAVID F. KAPP. ACUTE PANCREATITIS: A CLINICAL REVIEW OF 72 ATTACKS OCCURRING IN 54 PATIENTS(ACUTE PANCREATITIS: A CLINICAL REVIEW OF 72 ATTACKS OCCURRING IN 54 PATIENTS*). Ann Intern Med. 1958;48:1185–1193. doi: 10.7326/0003-4819-48-6-1185
Download citation file:
Published: Ann Intern Med. 1958;48(6):1185-1193.
Gastroenterology/Hepatology, Pancreatic Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use